Loading...
Docoh

SOPHiA Genetics (SOPH)

News

From Benzinga Pro
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $14
11 May 22
News, Price Target, Analyst Ratings
Morgan Stanley analyst Tejas Savant maintains Sophia Genetics (NASDAQ:SOPH) with a Overweight and lowers the price target from $17 to $14.
Sophia Genetics Q1 EPS $(0.34) Misses $(0.33) Estimate, Sales $10.90M Beat $10.85M Estimate
10 May 22
Earnings, News
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.33) by 3.03 percent. The company reported quarterly sales of $10.90 million which beat the
Earnings Scheduled For May 10, 2022
10 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
27 Recession-Resistant Stocks To Look At Now
9 May 22
News, Small Cap, Trading Ideas, General
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist. On the other hand, recession-resistant companies are what a savvy investor searches for during the absence of a bull market, as we are now.
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
28 Apr 22
News, Options, Intraday Update, Markets
During Thursday, 849 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
8 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's morning session, 234 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
25 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 166 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
24 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 112 stocks made new 52-week lows.
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $17
16 Mar 22
News, Price Target, Analyst Ratings
Morgan Stanley maintains Sophia Genetics (NASDAQ:SOPH) with a Overweight and lowers the price target from $18 to $17.
Stocks That Hit 52-Week Lows On Tuesday
15 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday's session, 454 stocks hit new 52-week lows.
Sophia Genetics Q4 EPS $(0.28) Beats $(0.36) Estimate, Sales $10.90M Miss $11.20M Estimate
15 Mar 22
Earnings, News
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.36) by 22.22 percent. The company reported quarterly sales of $10.90 million which missed the
Sophia Genetics Q4 Adj. EPS $(0.28) Beats $(0.36) Estimate, Sales $10.90M Miss $11.20M Estimate
15 Mar 22
Earnings, News
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.36) by 22.22 percent. The company reported quarterly sales of $10.90 million which missed the
Earnings Scheduled For March 15, 2022
15 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million.
SOPHiA GENETICS And REALM IDx Sign Letter Of Intent To Collaborate In Accelerating Cancer Research
14 Mar 22
Biotech, General
SOPHiA GENETICS (NASDAQ:SOPH) and REALM IDx announced today that they signed a letter of intent to collaborate in the co-development of novel genomic applications and commercialization of multi-modal applications.
SOPHiA GENETICS Announces SOFIVA GENOMICS To Adopt SOPHiA's Technology To Support HRD Testing
9 Mar 22
News
BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in
SOPHiA GENETICS Launches New Deep Learning Capabilities To Support The Detection Of Homologous Recombination Deficiencies
24 Feb 22
News
SOPHiA GENETICS (NASDAQ:SOPH), a leader in Data-Driven Medicine, announced today the launch of their SOPHiA DDM Homologous Recombination Deficiency (HRD) Solution, opening new doors for cancer research. The

Press releases

From Benzinga Pro
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022
10 May 22
Earnings, Press Releases
BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ:SOPH), a leader in data-driven medicine, today reported financial results for the first quarter ended March
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
5 May 22
Press Releases
BOSTON and LAUSANNE, Switzerland , May 5, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Directors. The Board
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
27 Apr 22
News, Press Releases
BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ:SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming J.P. Morgan 50th Annual
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
26 Apr 22
Press Releases
BOSTON and LAUSANNE, Switzerland, April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
13 Apr 22
Press Releases
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ:SOPH), a leader in data-driven medicine, today announced it will release its financial results for the first quarter of
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
15 Mar 22
Earnings, Press Releases
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ:SOPH), a leader in
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
14 Mar 22
Press Releases
The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON, ALISO VIEJO, Calif. and LAUSANNE,
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
9 Mar 22
Press Releases
BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan
SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies
24 Feb 22
Press Releases
The SOPHiA DDM HRD Solution offers cost-effective, accurate, reliable, timely, and easily implementable in-house results to empower better clinical research decisions BOSTON and LAUSANNE, Switzerland, Feb. 24, 2022